SAB Biotherapeutics (SABS) Assets (2020 - 2026)
SAB Biotherapeutics' Assets was $238.21 million in Q2 2026, up 690.6% from $30.13 million a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Assets at SAB Biotherapeutics came in at $172.81 million, up 291.0% from FY2024.
- Assets shows a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
- In earlier years, Assets was $44.2 million in FY2024 (-47.3%), $83.94 million in FY2023 (+64.9%), $50.9 million in FY2022 (-37.3%) and $81.14 million in FY2021 (+43.5%).
- Quarterly Assets has moved between $28.34 million (Q3 2023) and $248.47 million (Q1 2026) over five years.
- Compared with a year earlier, Assets has increased for four straight quarters, with growth averaging 214.9% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q2 2026 (growth of 690.6%); the worst was Q3 2022 (a decline of 55.1%).
- Per Business Quant data, SABS's Assets in the three quarters before Q2 2026 was $248.47 million (Q1 2026), $172.81 million (Q4 2025) and $183.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | 238.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 238.21 Mn |
| Mar 31, 2026 | 248.47 Mn |
| Dec 31, 2025 | 172.81 Mn |
| Sep 30, 2025 | 183.45 Mn |
| Jun 30, 2025 | 30.13 Mn |
| Mar 31, 2025 | 38.12 Mn |
| Dec 31, 2024 | 44.20 Mn |
| Sep 30, 2024 | 53.80 Mn |
| Jun 30, 2024 | 61.89 Mn |
| Mar 31, 2024 | 71.37 Mn |
| Dec 31, 2023 | 83.94 Mn |
| Sep 30, 2023 | 28.34 Mn |
| Jun 30, 2023 | 35.44 Mn |
| Mar 31, 2023 | 42.67 Mn |
| Dec 31, 2022 | 50.90 Mn |
| Sep 30, 2022 | 52.51 Mn |
| Jun 30, 2022 | 59.41 Mn |
| Mar 31, 2022 | 68.49 Mn |
| Dec 31, 2021 | 81.14 Mn |
| Sep 30, 2021 | 116.93 Mn |
API Access
SAB Biotherapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();